Considering nutritional status to improve outcomes of patients treated by atezolizumab–bevacizumab for advanced hepatocellular carcinoma
Liver International · 2024
DOI: 10.1111/liv.15887 ↗Kurz gefasst
Editorial in der Zeitschrift Liver International, 2024. Verfasst von Manon Allaire und 1 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Hépato-gastroentérologie, AP-HP Sorbonne Université, Hôpital Universitaire Pitié-Salpêtrière, Paris, France. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Antibodies, Monoclonal, Humanized, Bevacizumab. Die Arbeit nennt 15 Literaturangaben.
Themen: Mangelernährung
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service d'Hépato-gastroentérologie, AP-HP Sorbonne Université, Hôpital Universitaire Pitié-Salpêtrière, Paris, France.
- INSERM UMR 1138, Centre de recherche des Cordeliers, Paris, France.
- Genomic Instability, Metabolism, Immunity and Liver Tumorigenesis laboratory, Equipe Labellisée LIGUE 2023, Paris, France.
- Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.
- CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.
ORCID-Profile: Manon Allaire
Zitieren
APA
Allaire, M., & Avila, M. A. (2024). Considering nutritional status to improve outcomes of patients treated by atezolizumab–bevacizumab for advanced hepatocellular carcinoma. Liver International. https://doi.org/10.1111/liv.15887
Vancouver
Allaire M, Avila MA. Considering nutritional status to improve outcomes of patients treated by atezolizumab–bevacizumab for advanced hepatocellular carcinoma. Liver International. 2024. doi:10.1111/liv.15887
BibTeX
@article{Allaire2024,
author = {Allaire, Manon and Avila, Matias A},
title = {Considering nutritional status to improve outcomes of patients treated by atezolizumab–bevacizumab for advanced hepatocellular carcinoma},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.15887}
}
EUVIMED